Vector VestAdvertisement SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 2/1/2015 4:22:01 PM - Followers: 1204 - Board type: Free - Posts Today: 19
PostSubject
#186886  Sticky Note (CMRX/GENR)—Astute call on CMRX's Ebola program. Those kinds DewDiligence 02/01/15 01:07:07 PM
#186836  Sticky Note ABBV reports 95% SVR12 in Japanese GIFT-1 study DewDiligence 01/30/15 06:21:57 PM
#186823  Sticky Note EPRS sells 11.44M* shares @$5.00—a 23% discount to DewDiligence 01/30/15 01:41:20 PM
#186804  Sticky Note Viekira-Pak info from ABBV’s 4Q14 CC: DewDiligence 01/30/15 09:31:15 AM
#186788  Sticky Note Re: FMI Valuation DewDiligence 01/29/15 08:23:59 PM
#186784  Sticky Note ONCE IPOs (upsized) 8.05M* shares @$23.00, according to DewDiligence 01/29/15 06:34:36 PM
#186892   Per usual, zipjet, we are largely on the north40000 02/01/15 04:22:01 PM
#186891   One government enterprise Chinese company I have owned north40000 02/01/15 04:05:32 PM
#186890   >> Discussing what is "unreasonable" will produce more jq1234 02/01/15 03:45:29 PM
#186889   >>I fully support what PBM has been doing zipjet 02/01/15 03:12:41 PM
#186888   >> What do you mean? jq1234 02/01/15 02:55:21 PM
#186887   >>I am for free market control of drug zipjet 02/01/15 02:37:06 PM
#186886   (CMRX/GENR)—Astute call on CMRX's Ebola program. Those kinds DewDiligence 02/01/15 01:07:07 PM
#186885   Not too many Chinese companies I would want tpizzazz24 02/01/15 12:50:52 PM
#186884   To be clear: A Copaxone ANDA has not DewDiligence 02/01/15 12:21:08 PM
#186883   Mentioning or linking to other boards is fine, DewDiligence 02/01/15 12:18:26 PM
#186882   CBMG is essentially a Chinese company even though DewDiligence 02/01/15 12:15:16 PM
#186881   Where did Harvoni therapy enter the picture? I DewDiligence 02/01/15 12:05:22 PM
#186880   …how and why is AGTC under the radar?My DewDiligence 02/01/15 12:01:48 PM
#186879   This is definitely one of the best boards tpizzazz24 02/01/15 11:22:19 AM
#186878   Familiar with ZIOP but I would be foolish mr_o 02/01/15 09:18:32 AM
#186877   Hybio Pharma Sells US Rights For Generic Copaxone rwdm 02/01/15 07:19:55 AM
#186876   at that time is when specialist funds such lgonber 02/01/15 07:19:28 AM
#186875   watch cbmg ... this could be a tenbagger Exodus 02/01/15 05:26:47 AM
#186874   Thank you. Did I say it won't be long? Hope tpizzazz24 02/01/15 01:56:55 AM
#186873   Where did Harvoni therapy enter the picture? I north40000 01/31/15 09:29:37 PM
#186872   "In general" discussion is useless in this case. jq1234 01/31/15 09:14:59 PM
#186871   I do not understand what kind of "balance" north40000 01/31/15 09:01:45 PM
#186870   Under the radar: There are so few pure jq1234 01/31/15 08:22:46 PM
#186869   AGTC is under the radar screen for most DewDiligence 01/31/15 06:31:39 PM
#186868   They still have to design a phase 3 mr_o 01/31/15 04:18:48 PM
#186866   >>CMRX drops Ebola program biomaven0 01/31/15 02:58:10 PM
#186865   "We’re seeing some decidedly low-quality IPOs recently." To me, biotech_researcher 01/31/15 02:37:34 PM
#186864   AGTC A gene-therapy product need not be a iwfal 01/31/15 01:55:01 PM
#186863   CAPR—Looks like the impetus may have been insider buying: DewDiligence 01/31/15 01:35:27 PM
#186862   AGTC—…long-term follow-up from other trials indicates it isn't DewDiligence 01/31/15 01:29:56 PM
#186861   AGTC—I might not expect them to address the DewDiligence 01/31/15 01:27:40 PM
#186860   AGTC This is competitively sensitive stuff; I suspect iwfal 01/31/15 12:57:02 PM
#186859   AGTC abandoned the Leber Congenital Amaurosis program for iwfal 01/31/15 12:54:24 PM
#186858   This is competitively sensitive stuff; I suspect you DewDiligence 01/31/15 12:42:28 PM
#186857   AGTC’s AAV-vector technology has improved in the eight iwfal 01/31/15 12:34:44 PM
#186856   AGTC—Another key question is why Genzyme walked away DewDiligence 01/31/15 11:51:53 AM
#186855   AGTCPerhaps because they've got some failures? E.g. They mcbio 01/31/15 11:29:33 AM
#186854   AGTC abandoned the Leber Congenital Amaurosis program for DewDiligence 01/31/15 10:34:36 AM
#186853   We’re seeing some decidedly low-quality IPOs recently. DewDiligence 01/31/15 09:53:06 AM
#186852   AGTC is under the radar screen for most iwfal 01/31/15 08:55:26 AM
#186851   Patent issue in Germany. Apparently another company may ronpopeil 01/31/15 08:34:53 AM
#186850   I caught up on their latest press releases tpizzazz24 01/31/15 08:20:46 AM
#186849   What news are you looking for regarding CRMD? mr_o 01/31/15 08:16:41 AM
#186848   Looking for some more news on ZIOP XON tpizzazz24 01/31/15 01:48:56 AM
#186847   TCONTRC105, an anti-endoglin antibody that is being developed mcbio 01/30/15 11:00:18 PM
#186846   ENTA in mid 2013 was the kind of DewDiligence 01/30/15 08:00:48 PM
#186845   I find AGTC intriguing, but the trading volume oldberkeley 01/30/15 07:50:39 PM
#186844   Thanks for posting this very good news. Absence DewDiligence 01/30/15 07:34:26 PM
#186843   ZGNXJust received approval... bUrRpPPP! 01/30/15 07:15:56 PM
#186842   Addendum to #msg-110425636: ENTA gets a $30M milestone DewDiligence 01/30/15 06:53:53 PM
PostSubject